A Feasibility Study of Functional Lung Volume Preservation during Stereotactic Body Radiotherapy Guided by Gallium-

Gallium-68 perfusion PET/CT lung cancer stereotactic body radiation therapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
11 Mar 2023
Historique:
received: 27 02 2023
revised: 06 03 2023
accepted: 09 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

The aim of this study was to assess the feasibility of sparing functional lung areas by integration of pulmonary functional mapping guided by

Identifiants

pubmed: 36980612
pii: cancers15061726
doi: 10.3390/cancers15061726
pmc: PMC10046099
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ligue contre le cancer
ID : 12368

Références

Radiother Oncol. 2018 Nov;129(2):196-208
pubmed: 30082143
Technol Cancer Res Treat. 2016 Feb;15(1):114-21
pubmed: 25575575
Lancet Oncol. 2019 Apr;20(4):494-503
pubmed: 30770291
Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):611-616
pubmed: 35643253
Nat Rev Clin Oncol. 2012 Dec;9(12):712-20
pubmed: 23149896
Thromb Res. 2018 Mar;163:236-241
pubmed: 28673474
J Clin Oncol. 2022 Oct 1;40(28):3323-3343
pubmed: 35816668
Semin Nucl Med. 2019 Jan;49(1):71-81
pubmed: 30545520
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):172-187
pubmed: 30496880
Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1516-22
pubmed: 18495378
Cancer. 2012 Jun 1;118(11):2962-70
pubmed: 22020702
Front Med (Lausanne). 2021 Aug 27;8:723748
pubmed: 34513884
Lancet. 2012 Apr 7;379(9823):1341-51
pubmed: 22314182
Front Med (Lausanne). 2022 Nov 30;9:1051249
pubmed: 36530884
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1044-1052
pubmed: 26025776
Lancet. 2019 May 18;393(10185):2051-2058
pubmed: 30982687
Clin Oncol (R Coll Radiol). 2022 May;34(5):288-300
pubmed: 35272913
J Nucl Med. 2015 Nov;56(11):1718-23
pubmed: 26338892
Anticancer Res. 2022 May;42(5):2701-2709
pubmed: 35489736
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):878-86
pubmed: 22172903
Cancer Radiother. 2022 Feb-Apr;26(1-2):59-75
pubmed: 34953713
Pharmaceuticals (Basel). 2022 Apr 22;15(5):
pubmed: 35631345

Auteurs

François Lucia (F)

Radiation Oncology Department, University Hospital, 29200 Brest, France.
LaTIM, INSERM, UMR 1101, University of Brest, 29200 Brest, France.

Mohamed Hamya (M)

Radiation Oncology Department, University Hospital, 29200 Brest, France.

Fanny Pinot (F)

Service de Médecine Nucléaire, CHRU de Brest, 29200 Brest, France.

Gaëlle Goasduff (G)

Radiation Oncology Department, University Hospital, 29200 Brest, France.

Frédérique Blanc-Béguin (F)

Service de Médecine Nucléaire, CHRU de Brest, 29200 Brest, France.
GETBO, INSERM, UMR1304, Université de Bretagne Occidentale, 29200 Brest, France.

David Bourhis (D)

Service de Médecine Nucléaire, CHRU de Brest, 29200 Brest, France.
GETBO, INSERM, UMR1304, Université de Bretagne Occidentale, 29200 Brest, France.

Olivier Pradier (O)

Radiation Oncology Department, University Hospital, 29200 Brest, France.
LaTIM, INSERM, UMR 1101, University of Brest, 29200 Brest, France.

Anne-Sophie Lucia (AS)

Radiation Oncology Department, University Hospital, 29200 Brest, France.

Simon Hennebicq (S)

Service de Médecine Nucléaire, CHRU de Brest, 29200 Brest, France.
GETBO, INSERM, UMR1304, Université de Bretagne Occidentale, 29200 Brest, France.

Maëlle Mauguen (M)

Radiation Oncology Department, University Hospital, 29200 Brest, France.

Romain Floch (R)

Service de Médecine Nucléaire, CHRU de Brest, 29200 Brest, France.

Ulrike Schick (U)

Radiation Oncology Department, University Hospital, 29200 Brest, France.
LaTIM, INSERM, UMR 1101, University of Brest, 29200 Brest, France.

Vincent Bourbonne (V)

Radiation Oncology Department, University Hospital, 29200 Brest, France.
LaTIM, INSERM, UMR 1101, University of Brest, 29200 Brest, France.

Pierre-Yves Salaün (PY)

Service de Médecine Nucléaire, CHRU de Brest, 29200 Brest, France.
GETBO, INSERM, UMR1304, Université de Bretagne Occidentale, 29200 Brest, France.

Pierre-Yves Le Roux (PY)

Service de Médecine Nucléaire, CHRU de Brest, 29200 Brest, France.
GETBO, INSERM, UMR1304, Université de Bretagne Occidentale, 29200 Brest, France.

Classifications MeSH